Press releases

Eevia Health receives new sales orders for organic bilberry extract with a contract value of approx. SEK 3 million

Eevia Health Plc, ("Eevia" or "The Company"), announces that it has received sales orders from Ingredient Plus of Australia for supply of bilberry extract with minimum 36% anthocyanins. The sales value of these orders is c. SEK 3 million, which to be prepaid and delivered in Q3-21.

Eevia considers these orders to be repeat business with an expected value of c. SEK 7-9 million per year, based on forecast from the customer, with possible growth. The bilberry extract, which is sold under the Eevia tradename Feno-Myrtillus® Organic, is protected as a Proprietary Ingredient (PI) with the Therapeutic Goods Administration of Australia.

The end customer is an internationally recognized brand leader in the South-East Asian marketplace. The group has sales of c. USD 460 million and dietary supplements, including single herbs, vitamins, minerals, and specialty formulas sold under the Company's well recognized brands, in over 12 markets.

CEO Stein Ulve comments: "These sale orders consolidate our position as the preferred provider of high concentration and high-quality anthocyanin extracts from the wild harvested arctic bilberry, which are mainly harvested in Sweden and Finland. These are important orders for us because they are stable contributions to our order- and customer-base and hence, our ability to reach our financial targets of minimum annual turnover in 2024 of EUR 25 million with a gross margin at minimum 40%."

This disclosure contains information that EEVIA HEALTH PLC is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agencies of the contact person, on July 1, 2021.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                       Kim Nurmi-Aro, CFO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com                     kim@eeviahealth.com
Telephone: +358 400 22 5967                             +358 504 44 0717

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, is a small, but fast-growing Finnish manufacturer of 100% organically certified plant extracts. The Company addresses significant health problems with bioactive compounds extracted from plant material from the pristine Finnish forests near the Arctic Circle. The extracts, which have scientifically documented health benefits, are sold B2B as ingredients to dietary supplements and food brands globally. The focus is on ingredients that protect human health prophylactically, reducing the risk of deteriorating health. The products are targeted against immune health, low-grade inflammation, eye and brain health problems and metabolic disorders. In its portfolio.

Most of its raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion. The safe and effective ingredients of high quality, such as high concentrate bilberry anthocyanin extracts and pine bark extracts, are certified organic. Eevia Health operates a modern green-chemistry production facility in Finland, located close to the raw materials. The short value-chain enables an environmentally friendly carbon footprint, competitive pricing, and transparency.

The increasing health awareness among consumers, combined with the increased focus on sustainable business models, constitute a strong and significant macro-trend, from which Eevia stands well equipped to capitalize.

To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.

Information about Ingredient Plus

Ingredients Plus is a leading and independent distributor in the Asia-Pacific Region. Ingredients Plus recently celebrated it's 15-year anniversary. From its Head Office in Sydney, Ingredient Plus has quickly expanded across Australasia, Southeast Asia, and Greater China.

Ingredient Plus has a focus on key strategic markets, such as Beauty and Personal Care, Health, Pharmaceutical and Nutrition, and Household Care. Ingredients Plus specialize in providing advanced & innovative ingredients. Representing more than 20 key global manufacturers and thousands of products, Ingredients Plus supplies customers with complete solutions through flexible, reliable, and one-stop-shop supply of raw materials.

To learn more, please visit: www.ingredientsplus.com.au

2021-08-13
Regulatory

The Board and CEO of Eevia Health Plc hereby present the Interim Report for the second quarter 2021, covering the period April 1st through June 30th, 2021. The complete report with tables is attached to this release as a pdf-file. It is also available on the company website at www.eeviahealth.com 

2021-08-05

Eevia Health Plc, ("Eevia" or "The Company"), has installed new capacities and automation equipment for processing and evaporation of natural plant extract liquids. As of August 1st, the newly installed machines and technologies are working satisfactorily, with improved yield, productivity, and cost efficiency. These investments support the company's strong growth and strategic positioning, as communicated in the May 2021 information memorandum.

2021-07-01

Eevia Health Plc, ("Eevia" or "The Company"), announces that it has received sales orders from Ingredient Plus of Australia for supply of bilberry extract with minimum 36% anthocyanins. The sales value of these orders is c. SEK 3 million, which to be prepaid and delivered in Q3-21.

2021-06-29

Eevia Health Plc recently succeeded with an IPO equity round, issuing new 3 451 000 shares with gross proceeds of approx. SEK 26,2 million, leading to a total of 13 951 500 shares in the company as per today's date. Trading in shares will take place from today, June 29, 2021 at Spotlight Stock Market. The short name for the share is EEVIA.

2021-06-22
Regulatory

The Annual General Meeting of shareholders of Eevia Health Plc was held in Seinäjoki, on June 22, 2021. Two shareholders representing 3 797 500 shares and votes (36,14% of total shares) were represented at the meeting. The AGM decided each and all the proposals from the Board of Directors as described in the Notice of Annual General Meeting, unanimously.

2021-06-17

This is a correction to earlier press release today, which stated that the equity issue was over-subscribed by over 400%. The correct is subscribed by over 400%. Also in one media channel the MAR label was omitted by mistake in the Press release itself.

Eevia Health Plc ("Eevia"), a fast-growing functional foods company, today announces that the new share issue of approximately SEK 26.2 million prior to the planned listing on Spotlight Stock Market, was heavily oversubscribed. Subscriptions from over 3,500 investor accounts for a total subscription value of SEK 109.0 million means that the share issue was subscribed 4.16 times (or 416%). 

2021-06-17
Regulatory

Eevia Health Plc ("Eevia"), a fast-growing functional foods company, today announces that the new share issue of approximately SEK 26.2 million prior to the planned listing on Spotlight Stock Market, was heavily oversubscribed. Subscriptions from over 3,500 investor accounts for a total subscription value of SEK 109.0 million means that the share issue was subscribed 4.16 times (or 416%).

1
2